Metabolism of fructose to oxalate and glycolate
Poster Session I - NOVEL TARGET/ EXPERIMENTAL FIDINGS TO CLINICAL TRANSLATION 06.00 - NOVEL TARGET/ EXPERIMENTAL FIDINGS TO CLINICAL TRANSLATION - 06.02 - GENETICS, OMICS AND BIOMARKERS P463 - ESOC25-2074 PLASMA PTAU217 AS A BIOMARKER FOR POST-STROKE COGNITIVE IMPAIRMENT PREDICTION: A NESTED CASE-CONTROL STUDY Elena Escriche 1 , Mara Molina 1 , Mnica Macas 2 , Inhar Esnaola 1 , Adrin Jimnez 1 , Miren Roldan 2 , Amaya Urdnoz-Casado 2,3 , Nuria Sobrino 4 , Celia Fernndez 4 , Idoia Rubio 1 , Roberto Muoz 1,3 , Maria Herrera Isasi 1,3 , Maite Mendioroz 1,2,3 1 Neurology Department, University Hospital of Navarra, Pamplona, Spain, 2 Neuroepigenetics Unit, Navarrabiomed-UPNA, Pamplona, Spain, 3 Redes de Investigacin Cooperativa Orientadas a Resultados en Salud (RICORS)- ISC III, Madrid, Spain, 4 Radiology Department, University Hospital of Navarra, Pamplona, Spain Background and Aims: Post-stroke cognitive impairment (PSCI) represents a significant complication affecting stroke survivors
The injection is usually given in the thigh, abdomen, or upper arm, and it is important to follow the prescribed schedule to achieve optimal results
Swiss precision ensures safety and consistency
The incidence of fracture was over five times higher than in the general population
$35 per vial with batch-matched COA in every box
